2021-01-04,b'Going into 2021 with the following:\n$EVO / $EVVTY\n$CRWD\n$GRVY\n$SECARE\n$SE\n$SPOT\n$TDOC\n$NVCR\n$247\n$STNE\n$FVRR\n$EMBRAC\n$MELI\n$PINS\n$5DD\n$INSTAL\n$WATR.L\n$AOC\n$MWK\n$RVDT\n$LGVW\n$NNOX\n\nWould really like to have $SMLR in there but not worth it taxwise do to Swedish regulations'
2021-01-04,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-04,b'@Carsell30 $NVCR I agree not so sure about $SDGR'
2021-01-03,"b""RT @Carsell30: Med-tech companies saw some great % returns in 2020 but I still think there's scope for outsized gains in the next 5 years o\xe2\x80\xa6"""
2021-01-03,b'@DynamicMec Have pos in most bio fan favs: $dmtk $iova $asnd $bpmc $crsp $exas $fate $gh $kod $nvcr $stok &amp; while these can go higher- many have run too far for M&amp;A to make strategic + $ sense! The ones that haven\xe2\x80\x99t ran yet: $kala $gthx $kpti $evfm $chma $zgnx $fgen $onct $tril $espr $dtil'
2021-01-03,"b""Med-tech companies saw some great % returns in 2020 but I still think there's scope for outsized gains in the next 5 years or so. Some of my favourites:\n\n$NVCR \n$SDGR\n$SLP\n$TDOC"""
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,"b'RT @gamechangercap: $NVCR ""One day every cancer patient will use our product"": https://t.co/XXUKUnPw2H | via @GlobesEnglish #gamechanger Go\xe2\x80\xa6'"
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,"b""$NVCR this is my largest holding for a reason. Shared this a few days ago but take a few minutes to read the article if you haven't. https://t.co/9MR7dNFHMM"""
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,"b'@LuoshengPeng $NVCR electrical waves to treat cancer, across every type of solid tumors'"
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,b'RT @BrianFeroldi: Med-tech is a great industry to get to know\n\nStudy these stocks to learn more:\n\n$ABMD\n$ALGN\n$AMWL\n$DXCM\n$GDRX\n$GH\n$IRTC\n$\xe2\x80\xa6'
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-03,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'@PatternProfits @Gambiste1 $BCLI is like $NVCR in 2016. Getting ready to rip. Way oversold right here'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,"b'RT @StockZombie: My 2020 FA most read: $MGNI, $GBT, $SE, $TMDX, $SGDR, $PINS, $NVCR, $QTRX, $NVTA, $RPTX\nYou can read all this and more in\xe2\x80\xa6'"
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,"b'My 2020 FA most read: $MGNI, $GBT, $SE, $TMDX, $SGDR, $PINS, $NVCR, $QTRX, $NVTA, $RPTX\nYou can read all this and more in my personal site:\nhttps://t.co/jKnindOlav'"
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'@DrHaluska Would completely agree! I was in at $65 a share and they are making the world a better place and giving cancer patients a longer life to live ! They have excellent leadership and patented technology that is proven to work. Thanks @BrianFeroldi for making me aware of $NVCR'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,"b'RT @FearAndGreed3: #watchlist for our stocks that we feel are primed for an imminent break-out, but did not quite make our Top 3: \n\n$AMBA,\xe2\x80\xa6'"
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6\xe2\x80\xa6'
2021-01-02,b'Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $NGMS\n2) $GRWG\n3) $CRWD\n4) $DQ\n5) $MXL\n6) $LOVE\n7) $NVCR\n8) $FUTU\n9) $PTON\n10) $ZS\n\nThese are NOT setups. Traders must still find a proper entry point if planning a purchase.'
2021-01-02,"b'Top 10 holdings by market value going into 2021:\n$XPEL\n$AAPL\n$LOGI\n$ISRG\n$IDXX\n$BKNG\n$M44U.SI\n$CRWD\n$CSU.TO\n$BRK.B\n$ILMN\n\nOther smaller holdings: \n$NVCR, $MVP.TO, $NET, $STNE, $MELI, $SMLR, $BL, $SE'"
2021-01-02,b'$NVCR NovoCure Limited - Ordina Top stock up 205% from low. Close: 173.04 VolvsAvg: 0.43 Liq: $73M https://t.co/tJRu993M6o'
2021-01-01,b'My biggest winners (biggest +48%)\n- $APPS - $NCLH - $NIO  $ROKU - $PINS - $MELI - $OTRK - $PDD - $JMIA - $LMND\n\nMy biggest Lossers (Biggest -3%)\n- $CELH - $XP - $GOGO - $DAL - $NVCR - $CGC - $PHM (spain) - $OXY - $NNOX - $HUYA'
2021-01-01,"b""January portfolio update (by position size): \n\n$NVCR \n$NET\n$ZLAB\n$BTC\n$PSNL\n$TMDX\n$FLGT\n$SILK\n$CCCC\n$BYSI\n$SWAV\n$GWPH\n$FREQ\n$PROF\n$AYX\n$ETH\n\nOptions: $NVCR Jan \xe2\x80\x9822 $115 calls &amp; mar \xe2\x80\x9821 $145 calls \n\n$SH Feb '21 $20 calls , $SQQQ Mar '21 $20 calls, $BIS Jan '21 $26 calls"""
2021-01-01,"b'$NVCR ""One day every cancer patient will use our product"": https://t.co/XXUKUnPw2H | via @GlobesEnglish #gamechanger Going to be a huge 2021'"
2021-01-01,b'@Ezehtim Reminds me $NVCR'
2021-01-01,"b""$nvcr - 5%\n\nNovocure's physics-based cancer treatments eliminate many side-effects of existing therapies. Proven track-record and potent pipeline are promising. Great company to cheer for."""
2021-01-01,"b'@SupesesClub \xf0\x9f\x92\xaf on $kala -best r/r in bioland at moment imo! While eye care may not be as sexy as rare diseases/onc/gene/screening biz like $onct $iova $dmtk $tril $psnl $txg $nvcr $exas (&amp; many other fan favs I\xe2\x80\x99ve also owned), I\xe2\x80\x99m betting the return on KALA will outpace them all in 2021. GL'"
2021-01-01,"b""#401KBeatTheSpy -retirement acc - 401K SDBA gives you lots of flexibility, I like it.\n\n2020: +142.13% - I don't think this is going to last \xf0\x9f\x98\xac\n\nIn order of size $NET $ROKU $NVCR $CRWD $FLGT $BAND $HZNP $PSNL $TDOC $GDRX $ARWR $NARI $ALNY $DDOG $VEEV $GWPH $GBT $BTAI $DRNA $QTNT https://t.co/OwsUgONugx"""
2021-01-01,b'#BeatTheSpy\nPortfolio update - End of 2020\n\n2020: +71.11% / Since 1/1/19:\n+151.39%\n\nLiquidated: ~15% across acc to deploy into school loan \nReduced: $ARWR\nAdded: $ALNY $HZNP\n\nIn order of size $NET $NVCR $ARWR $CRWD $HZNP $FLGT $GWPH $ASND $TDOC $BAND $ALNY $GDRX $AYX $DRNA $QTRX https://t.co/Vlav5rCafS'
2021-01-01,b'@GrowthStockInv1 Yup $SWAV should become standard of care. $NVCR is my largest position by far. Lots of catalysts in 2021. $TMDX could easily be a $100 stock again lots of catalysts in 21'
2021-01-01,"b""@GrowthStockInv1 I'm not in the typical names you hear on fintwit. $NVCR $TMDX $SWAV"""
2021-01-01,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2021-01-01,b'RT @BrianFeroldi: What companies have either: \n\n1) No direct competition (blue ocean strategy)\n2) Are near-monopolies\n\nMy list:\n\n$ABMD\n$ASR\xe2\x80\xa6'
2021-01-01,b'RT @BrianFeroldi: What companies have either: \n\n1) No direct competition (blue ocean strategy)\n2) Are near-monopolies\n\nMy list:\n\n$ABMD\n$ASR\xe2\x80\xa6'
2021-01-01,"b'(35) Bias &amp; Snap Judgements.\n\nMissed out investing in $NVCR, $CVNA, $ETSY, $U, $PINS earlier on. Without any deep drives &amp; reading the 10K, I let my bias cloud my judgement to lead me to come to an incorrect conclusion. To not repeat this ever.'"
2021-01-01,b'$NVCR NovoCure Limited - Ordina Top stock up 205% from low. Close: 173.04 VolvsAvg: 0.42 Liq: $72M https://t.co/tJRu993M6o'
2021-01-01,b'$NVCR Was up 2.21 %. Turned negative -0.47% | (Green to red move) #GreenToRed https://t.co/GVxlCwgmt1 https://t.co/MHtyNfkYJo'
2020-12-31,b'Well this sums up my performance in 2020 $NVCR $NET $ZLAB'
2020-12-31,b'RT @paul_essen: End of 2020 top holdings:\n\n$SHOP 13%\n$TSLA 12%\n$MELI 10%\n$SE 7%\n$AMZN 7%\n$RDFN 5%\n$TTD 5%\n$TDOC 6%\n$SQ 5%\n$NVCR 5%\n$ROKU 4%\xe2\x80\xa6'
2020-12-31,b'End of 2020 top holdings:\n\n$SHOP 13%\n$TSLA 12%\n$MELI 10%\n$SE 7%\n$AMZN 7%\n$RDFN 5%\n$TTD 5%\n$TDOC 6%\n$SQ 5%\n$NVCR 5%\n$ROKU 4%\n$DIS 4%\n$JD 3%\n$ETSY 2%\n$NFLX 2%\n$CRWD 2%\n$FSLY 2%\n$FVRR 2%\n$ZM 1%\n$NNOX 1%\n\n2020 Returns: 175%'
2020-12-31,"b""2020 My Best Performing Stock \n1. $MGNI\n2. $APPN\n3. $PINS\n4. $FVRR\n5. $TTD\n6. $NVCR\n7. $SE\n8. $SQ\n9. $DMTK\n10. $ETSY\n\nJust missed: $CRWD $MELI\n\n$MGNI is the king with call options on it doing well too\n\n2020 was something. I wonder if I will ever beat this year's return."""
2020-12-31,b'$NVCR Was up 2.21 %. Turned negative -0.70% | (Green to red move) #GreenToRed https://t.co/GVxlCwgmt1 https://t.co/mausWwOrdW'
2020-12-31,b'@gamechangercap @TheMarkCooke love $NVCR!'
2020-12-31,b'$NVCR Is The Rally In Novocure Overdone? https://t.co/iG3w5S0r0R'
2020-12-31,b'Best performing large cap stocks so far today\n\nEnphase $ENPH\nYatsen $YSG\nBeiGene $BGNE\nWestern Digital $WDC\n$NIO\nAvantor $AVTR\nXPeng $XPEV\nLufax $LU\nMicron $MU\nCnooc $CEO\nImperial $IMO\nChina Sourthern $ZNH\n10x $TXG\nTC Energy $TRP\nFranco $FNV\nNovoCure $NVCR\nModerna $MRNA\n$NWG\n$FB'
2020-12-31,"b""RT @teddyisreadyy: Positions I'm continuing to accumulate on weakness\n\n$RADA\n$ORGO\n$OM\n$NVCR\n$DKNG\n$FVRR\n$DOCU\n$NET\n$SHOP"""
2020-12-31,"b'RT @duckman1717: Of my TML List, $NVCR, $APPS, $TSLA, $OKTA, $GRWG, and $PTON standout on this thin half day. \n\nOther Notable Leaders like\xe2\x80\xa6'"
2020-12-31,"b""Positions I'm continuing to accumulate on weakness\n\n$RADA\n$ORGO\n$OM\n$NVCR\n$DKNG\n$FVRR\n$DOCU\n$NET\n$SHOP"""
2020-12-31,b'$NVCR NovoCure Limited - Ordina Top stock up 205% from low. Close: 174.14 VolvsAvg: 0.62 Liq: $112M https://t.co/tJRu993M6o'
2020-12-31,b'genomics : $NVTA $EXAS $PSNL $CRSP $EDIT\nhealthcare : $ISRG $NVCR $PGNY\ncyber security : $CRWD $OKTA $ZS \nE commerce : $SHOP $SE $MELI \nFintech : $SQ'
2020-12-31,b'RT @GreatStockMark1: Hyper Growth stocks moved nicely today after some pullback last few days. Still some needs to recover from strong down\xe2\x80\xa6'
2020-12-31,"b'Tomrrow\xe2\x80\x99s #watchlist for #NYSE, #NASDAQ between $150 and $200: $ALXN $APPN $CRSP $CYBR $DIS $EDU $ENPH $ETSY $FIVE $IAC $IWM $JAZZ $JNJ $LHX $LLY $NVCR $PDD $PTON $QRVO $SE $ZTS'"
2020-12-31,b'Hyper Growth stocks moved nicely today after some pullback last few days. Still some needs to recover from strong down trend like $DADA. \n$CELH $APPS $GRWG $DADA $FTHM $NVCR $TRUP $GOGO $RKT $CRNC $OSTK $WKHS $PLL $BIGC $FLGT $EXPI $PSNL $stocks #stockstwatch #stockscreener https://t.co/mWwpeB23N4'
2020-12-30,b'RT @JoeySolitro: My 10 Largest Positions as of 12/21/20 at 2:25pm (excluding custodian accounts):\n\n1) $ETSY\n2) $PLTR\n3) $NVCR\n4) $FTCH\n5) $\xe2\x80\xa6'
2020-12-30,b'RT @MisterFili: Healthcare devices I\xe2\x80\x99m keeping an eye on for the next 3-5yrs\n\n$NNOX - digital imaging \n$NVCR - Cancer treatments\n$OM - dial\xe2\x80\xa6'
2020-12-30,b'@JoeySolitro Healthcare / biotech:\n\n$MEDS\n$MMEDF \n$NVCR\n$PGNY\n$NNOX\n\nFactors needed: \n- FDA approval for med devices \n- Growth for telehealth plays \n- Awareness and training for ALL'
2020-12-30,b'Healthcare devices I\xe2\x80\x99m keeping an eye on for the next 3-5yrs\n\n$NNOX - digital imaging \n$NVCR - Cancer treatments\n$OM - dialysis treatment \n$LGVW / Butterfly iQ - digital imaging'
2020-12-30,"b'$NVCR options chain, larger bets for near the money PUTS for Jan 15 options.  $NWBO TLD before to cause a drop in NVCR PPS? https://t.co/DnHa9c9lVJ'"
2020-12-30,"b'$NVCR  Northland Securities Maintains Buy Rating On Novocure, $200 PT https://t.co/M70AAKrCBk'"
2020-12-30,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2020-12-30,"b""RT @ebcapital: Here are some of the medtech plays I'm \xf0\x9f\x91\x80as we go into 2021:\n$NVCR\n$PODD\n$EAR\n$AXNX\n$STAA\n$ATRC\n$SWAV\n$LGVW\n$IRTC"""
2020-12-30,b'$NVCR $ZLAB Back to back presentations at JPM on the 12th https://t.co/h6OWpxQlQv'
2020-12-30,"b'@clueless_1337 Specs, spacs and qual stocks that must graduate to LT holds that are testbed stocks. $abnb $ai $band $bigc $blfs $btwn $cci $chwy $dao $ddog $docu $ehth $frog $fubo $gild $goev $lmnd $jmia $lazr $haacu $open $gwrg $mgni $mu $mwk $net $nvcr $nio $ncno $ostk $otrk $ozon $yndx $xpev'"
2020-12-30,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2020-12-30,b'$NVCR NovoCure Limited - Ordina Top stock up 201% from low. Close: 168.96 VolvsAvg: 0.71 Liq: $137M https://t.co/tJRu993M6o'
2020-12-29,b'RT @BrianFeroldi: Med-tech is a great industry to get to know\n\nStudy these stocks to learn more:\n\n$ABMD\n$ALGN\n$AMWL\n$DXCM\n$GDRX\n$GH\n$IRTC\n$\xe2\x80\xa6'
2020-12-29,b'$NVCR Is a stock that isn\xe2\x80\x99t giving much back despite a lot of leaders correcting. https://t.co/PoE7yK0dVI'
2020-12-29,b'RT @JoeySolitro: My 10 Largest Positions as of 12/21/20 at 2:25pm (excluding custodian accounts):\n\n1) $ETSY\n2) $PLTR\n3) $NVCR\n4) $FTCH\n5) $\xe2\x80\xa6'
2020-12-29,"b""Actually, I'm long $NVCR.. Others I'm not long yet."""
2020-12-29,"b""Stocks I don't own that I'm \xf0\x9f\x91\x80 this week:\n$QRVO\n$PTON\n$RAVN\n$IPOC\n$LOVE\n$IIVI\n$ADYEY\n$RPD\n$SAIL\n$CDXS\n$AXNX\n$W\n$PODD\n$NVCR"""
2020-12-29,"b""RT @PatternProfits: Left sides of new bases feel awful when you've had a big run, but they're necessary for a healthy climb to continue. $P\xe2\x80\xa6"""
2020-12-29,b'RT @PatternProfits: Of note.\n\nInside day - $PTON $ENPH $FVRR $NVCR $COUP $FROG $FSLY $SMAR $CELH $GPN $TMHC $ZI $APT $DKNG $GOCO $GNMK $CHW\xe2\x80\xa6'
2020-12-29,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $EXPI\n2) $PTON\n3) $APPS\n4) $ENPH\n5) $NVC\xe2\x80\xa6'
2020-12-29,b'RT @PatternProfits: Of note.\n\nInside day - $NVCR $SQ $EXPI $SEDG $ENPH $QDEL $TEAM $AMZN $ZYXI $ZS $U $SNOW $FTCH $LMND $ESTC $LMPX $AOUT\xe2\x80\xa6'
2020-12-29,b'$NVCR how many catalysts next year? https://t.co/byhij6arEK'
2020-12-29,"b""RT @ebcapital: Here are some of the medtech plays I'm \xf0\x9f\x91\x80as we go into 2021:\n$NVCR\n$PODD\n$EAR\n$AXNX\n$STAA\n$ATRC\n$SWAV\n$LGVW\n$IRTC"""
2020-12-29,"b'RT @duckman1717: From an earnings runway perspective (2020, 2021, or 2022 estimates), these are the finest I can find: \n\n$DOCU $HZNP $APPS\xe2\x80\xa6'"
2020-12-29,b'$NVCR NovoCure Limited - Ordina Top stock up 201% from low. Close: 169.79 VolvsAvg: 0.46 Liq: $98M https://t.co/tJRu993M6o'
2020-12-29,"b'$TDOC telehealth is a permanent fixture in healthcare, quickly cross-selling with Livongo, creating the #1 stop for end-to-end digital healthcare\n$NVCR is saving lives and making money doing it. 5y survival for glioblastoma almost 3x standard treatment. Gross margin 79%.'"
2020-12-29,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2020-12-29,b'RT @stephan_1969: @RichardMoglen $UMC $HIMX $QS $EDIT $CRIS $ASO $ATVI $SITM $NVCR $ALGN $OPRX $ISRG $SSTK $FTHM $CRSR $REGI $AVNW $DNLI $P\xe2\x80\xa6'
2020-12-29,"b""RT @ebcapital: Here are some of the medtech plays I'm \xf0\x9f\x91\x80as we go into 2021:\n$NVCR\n$PODD\n$EAR\n$AXNX\n$STAA\n$ATRC\n$SWAV\n$LGVW\n$IRTC"""
2020-12-29,b'@RichardMoglen $UMC $HIMX $QS $EDIT $CRIS $ASO $ATVI $SITM $NVCR $ALGN $OPRX $ISRG $SSTK $FTHM $CRSR $REGI $AVNW $DNLI $PSNL $FOUR $LOVE $VIPS \nAll stocks I do not own... sigh'
2020-12-28,b'Biotech/HC New or revisited 52-Week Highs: $ACRS $ALLK $ATEC $ATRC $BASI $SPRO $CLLS $APLS $CNMD $CRIS $CYTR $EPIX $ERB $IDXX $INCR $JAZZ $KMPH $LAKE $NTLA $NTRA $NVCR $NXTM $SAGE $SGMO $SKLN $SMLR $TECH $UTHR $VCEL $XOMA $QQQ'
2020-12-28,"b'$IPOC $AMZN $BABA \n\nLong ipoc sold  +7 per share BOOM, \nLong Baba sold +10 per share BOOM, \nLong Amzn sold  +60 per share BAm bam\n\n We did great how did you do ? \n\nStill have open postion $BIGC $NVDA $AAPL $SNOW $NVCR $AMD \xf0\x9f\x90\x9d'"
2020-12-28,"b""RT @ebcapital: Here are some of the medtech plays I'm \xf0\x9f\x91\x80as we go into 2021:\n$NVCR\n$PODD\n$EAR\n$AXNX\n$STAA\n$ATRC\n$SWAV\n$LGVW\n$IRTC"""
2020-12-28,"b""RT @ebcapital: Here are some of the medtech plays I'm \xf0\x9f\x91\x80as we go into 2021:\n$NVCR\n$PODD\n$EAR\n$AXNX\n$STAA\n$ATRC\n$SWAV\n$LGVW\n$IRTC"""
2020-12-28,"b""@ebcapital Likewise, I'll be watching $SWAV $NVCR $LGVW. Additionally on my list $NARI $GMED $SMLR"""
2020-12-28,"b""RT @ebcapital: Here are some of the medtech plays I'm \xf0\x9f\x91\x80as we go into 2021:\n$NVCR\n$PODD\n$EAR\n$AXNX\n$STAA\n$ATRC\n$SWAV\n$LGVW\n$IRTC"""
2020-12-28,"b""Here are some of the medtech plays I'm \xf0\x9f\x91\x80as we go into 2021:\n$NVCR\n$PODD\n$EAR\n$AXNX\n$STAA\n$ATRC\n$SWAV\n$LGVW\n$IRTC"""
2020-12-28,b'RT @PatternProfits: Inside - $PLTR $AMZN $EXPI $TTCF $AMD $NIU $LOB $HZNP $MRVI $LOVE $PMT $UI $Z $SMAR $DOMO $PD $SWAV $ZBRA $WSM $NOVA $A\xe2\x80\xa6'
2020-12-28,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $EH\n2) $YALA\n3) $GRWG\n4) $PLTR\n5) $NVCR\xe2\x80\xa6'
2020-12-28,b'RT @PatternProfits: Daily Velocity Scan for 12/10. 57 names (+400). $SFIX strong post-EPS follow through continues. $SI right back at it of\xe2\x80\xa6'
2020-12-28,b'RT @CalebFranzen: $NVCR - UPDATE: Failed breakout once again. Tough. Putting stop order at $164 (breakeven level for my position). https://\xe2\x80\xa6'
2020-12-28,b'$NVCR - UPDATE: Failed breakout once again. Tough. Putting stop order at $164 (breakeven level for my position). https://t.co/SlRkadpBUO'
2020-12-28,b'RT @dennisc230: Sentiment indicators remain elevated so some caution is warranted. Make sure to have an action plan should the market turn\xe2\x80\xa6'
2020-12-28,b'New 52 Week High today: $ATR $SOAC $CP $IPAY $STIP $IJH $AVK $FLEX $CFACU $BCOV $VONG $PTC $PBW $XHB $VIOO $HCAT $DBDR $IWL $NVCR $FXL ... https://t.co/4Iw0QeR3p8'
2020-12-28,"b'Stocks with greater movement, last 15 minutes\n\n$MVIS +/- 3.2% MicroVision Inc.\n$NTLA +/- 1.95% Intellia Therapeutics Inc.\n$MYOV +/- 1.91% Myovant Sciences Ltd.\n$NVCR +/- 1.91% NovoCure Limited\n$CSIQ +/- 1.75% Canadian Solar Inc.\nhttps://t.co/TWuFzGUpzf'"
2020-12-28,"b""This morning's all-time highs: $PGNY $NVCR $NARI and 10% mover $LMND \xe2\xac\x87\xef\xb8\x8f"""
2020-12-28,"b""$NVCR - UPDATE: Price finally breaks out with decisiveness, up +3.5% this morning. Some consolidation around the upper-bound is ordinary &amp; doesn't change the bullish price action of the breakout. Obviously, need to see price hold above $175 now. Currently $177.99. https://t.co/qDcc62fDGt https://t.co/F57DKVQ3nA"""
2020-12-28,b'11) $NVCR hit a 52-week high last Thursday https://t.co/6fBRZ3lzpD'
2020-12-28,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2020-12-28,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2020-12-28,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2020-12-28,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2020-12-28,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2020-12-28,b'RT @JoeySolitro: My 10 Largest Positions as of 12/21/20 at 2:25pm (excluding custodian accounts):\n\n1) $ETSY\n2) $PLTR\n3) $NVCR\n4) $FTCH\n5) $\xe2\x80\xa6'
2020-12-28,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2020-12-28,b'RT @PatternProfits: Strong estimates for future growth from top groups.\n\nFocus list Top 10....\n\n1) $EH\n2) $YALA\n3) $GRWG\n4) $PLTR\n5) $NVCR\xe2\x80\xa6'
2020-12-28,b'RT @BrianFeroldi: Med-tech is a great industry to get to know\n\nStudy these stocks to learn more:\n\n$ABMD\n$ALGN\n$AMWL\n$DXCM\n$GDRX\n$GH\n$IRTC\n$\xe2\x80\xa6'
2020-12-28,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2020-12-28,b'$NVCR super strong we are still long . \xf0\x9f\x90\x9d\n\n#NVCR'
2020-12-27,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2020-12-27,"b'RT @richard_chu97: Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SE\xe2\x80\xa6'"
2020-12-27,"b'Healthcare: $TDOC, $EDIT, $CRSP, $SDGR, $NVTA, $GH, $EXAS, $NVCR, $PSNL, $CMPS, $MMED\n\nClimate Change: $TSLA, $ENPH, $SEDG, $FSLR\n\nEducation: ???\n\nSpace: $SPCE'"
2020-12-27,"b'#watchlist for our stocks that we feel are primed for an imminent break-out, but did not quite make our Top 3: \n\n$AMBA, $VOXX, $Z, $DAR, $FTHM, $MPWR, $NVCR, $ON, $RAMP, $DADA, $PDD, $HALO\n\nWe already hold positions in $AMBA, $FTHM and $RAMP'"
2020-12-27,"b'My top investment ideas for 2021. I own all of these currently. Major themes Edge networks, medtech, and crypto \n\n$NET\n$NVCR\n$TMDX \n$SWAV / $SILK\n$PROF\n$ETH / $BTC\n$CCCC'"
2020-12-27,b'RT @pslucky13: @bburnworth @Abundance360 Check in the above subject:\n\n$EDIT\n$NTLA \n$BEAM\n$CRSP\n\n$NVCR'
2020-12-27,b'@bburnworth @Abundance360 Check in the above subject:\n\n$EDIT\n$NTLA \n$BEAM\n$CRSP\n\n$NVCR'
2020-12-27,b'RT @jaywhitcraft: Favorites for next week \xe2\x80\x93 $AAPL $ACB $AMD $AMZN $APPS $COUP* $CRWD $CVAC $DOCU $ETSY $EXPI $FOUR $FUTU $IIPR $JKS* $KC $K\xe2\x80\xa6'
2021-01-08,b'RT @paul_essen: Fantasy Investing 2021 is officially underway! Good luck to all the participants. My horses are:\n$CRWD $ETSY $NVCR $SE $TDO\xe2\x80\xa6'
2021-01-07,"b'$UBER $AMZN \n\nUber 60c Jan 2022 sold 5 +2.1per contract, \nAmzn 3600c feb 19 sold +4 contract\n\nAnother amazing day in room we riding winners $NVCR $TSLA $IPOE $HALO \xf0\x9f\x90\x9d'"
2021-01-07,b'$NVCR nice spot to try. https://t.co/KXURuiNube'
2021-01-07,b'Winners of the day \n\n$NVCR $ZLAB $SWAV $NET $FLGT $PSNL $NRIX $OTRK $GBTC'
2021-01-07,b'RT @evaluatevantage: Telemedicine and the \xe2\x80\x9cZoom effect\xe2\x80\x9d boost big-cap medtech https://t.co/WzHd5zqRbN $TDOC $NVCR $BSX $BDX'
2021-01-07,b'Telemedicine and the \xe2\x80\x9cZoom effect\xe2\x80\x9d boost big-cap medtech https://t.co/WzHd5zqRbN $TDOC $NVCR $BSX $BDX'
2021-01-07,b'Taking profit on your biggest gaining stock is like getting rid of the best player on your sports team. \n\nIt\xe2\x80\x99s like the lakers getting rid of Lebron James because he\xe2\x80\x99s getting too many triple doubles \n\nLet your winners run !!!\n\n*Cough* $ROKU $CRWD $SQ $NVCR $CRSP'
2021-01-07,"b'SolarEdge Technologies $SEDG has overtaken Check Point Software $CHKP , NICE Systems $NICE &amp; NovoCure $NVCR to become the most valuable Israeli company traded on Wall Street:\n\nhttps://t.co/Dx39RZYIDz'"
2021-01-07,"b'RT @sentimentstock: What type of fuzzy math did $NVCR use to claim 43% of trial patients using Optune+chemo were alive at 2 yrs, when their\xe2\x80\xa6'"
2021-01-06,b'Down 2.4%. Led by losses in $SE $FSLY $FUTU $TWLO $APPS $TTD. \nBot $FUTU $FTCH $U.  Started $NIO.\nSold $NVCR (low conviction position).\n\xf0\x9f\x99\x8f\xf0\x9f\x99\x8f'
2021-01-06,"b'What type of fuzzy math did $NVCR use to claim 43% of trial patients using Optune+chemo were alive at 2 yrs, when their own JAMA charts show vastly different results?\n\n43/n=346, so 12%, not 43%\n\n$NWBO \'s #DCVax-L \n""BLENDED"" results \nhas 46.2% alive at the 2 yr mark.  \n\nC\xe2\x80\x99mon, man https://t.co/zf5N7uImeY'"
2021-01-06,"b'Large Print $NVCR Size: 105869 Price: 157.53 Time: 1600 Amount: $16,677,543.57'"
2021-01-06,b'RT @gamechangercap: @BullishAngel I mean how much time do you have. I post about them all the time. $NVCR pipeline basically derisked tons\xe2\x80\xa6'
2021-01-06,"b""RT @sentimentstock: $NVCR's Optune Trial:\n\n13/346 [based on Fig.3 # from Jama/not 466] \n(TTF &amp; SOC) lived 5 yrs\n= .0375%\n\n8/229 \n(SOC alone\xe2\x80\xa6"""
2021-01-06,b'@BullishAngel I mean how much time do you have. I post about them all the time. $NVCR pipeline basically derisked tons of readouts. $ZLAB has rights to optune in all of China plus a bunch of other drugs. $NET is innovating like crazy the edge is the future for security'
